InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Quart Barry D, Chief Executive Officer. Director active across 4 companies, notably Heron Therapeutics, INC.. Cumulatively, 20 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €859k. Activity tracked since 30 April 2021. The latest transaction was filed on 19 August 2026 (Don). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Quart Barry D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
2,600 shares0Class A Ordinary ShareSEC:0001384243-26-000014:0
13,099 shares@ US$14.331.94% mcap22.2% of flowClass A Ordinary ShareSEC:0001384243-26-000010:0
13,099 shares@ US$50.106.77% mcap77.8% of flowClass A Ordinary ShareSEC:0001384243-26-000010:1
6,901 shares@ US$14.337.8% of flowClass A Ordinary ShareSEC:0001384243-26-000008:0
6,901 shares@ US$50.0027.1% of flowClass A Ordinary ShareSEC:0001384243-26-000008:1
110 shares@ US$15.470.1% of flowClass A Ordinary ShareSEC:0001384243-26-000004:0
830 shares@ US$15.470.8% of flowClass A Ordinary ShareSEC:0001384243-26-000002:0
20,129 shares@ US$10.3613.6% of flowClass A Ordinary ShareSEC:0001384243-25-000004:0
6,900 shares@ US$3.802.0% of flowClass A Ordinary ShareSEC:0001415889-25-016724:0
3,173 sharesClass A Ordinary ShareSEC:0001415889-25-015784:0
4,373 sharesClass A Common ShareSEC:0001415889-24-015994:0
5,000 sharesClass A Common ShareSEC:0001415889-23-010559:0
1,655 shares@ US$3.272549.7% of flowCommon StockSEC:0001209191-23-003563:0
21,959 shares@ US$1.59100.0% of flowClass A Common ShareSEC:0001415889-22-011878:0
3,646 sharesCommon StockSEC:0001209191-22-053835:0
1,504 shares@ US$3.84250.3% of flowCommon StockSEC:0001209191-22-042262:0
3,646 sharesCommon StockSEC:0001209191-22-024522:0
3,646 sharesCommon StockSEC:0001209191-22-003362:0
3,646 sharesCommon StockSEC:0001209191-21-060551:0
1,529 shares@ US$13.8975100.0% of flowCommon StockSEC:0001209191-21-046790:0
20 of 20 declarations
About Quart Barry D
Quart Barry D is Chief Executive Officer and is associated with Kiniksa Pharmaceuticals International, plc, Heron Therapeutics, INC., Kiniksa Pharmaceuticals, Ltd. and HERON THERAPEUTICS, INC. /DE/. Across 19 filings in total, the 19 sampled filings cover the period from 2021-07-15 to 2026-04-29 and show EUR 0 of purchases and EUR 859024 of sales, with Levée d'options as the most frequent transaction nature.
